(Q44261949)

English

A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

A comparison of cefditoren pivoxil and amoxicillin/ clavulanate in the treatment of community-acquired pneumonia: a multicenter, prospective, randomized, investigator-blinded, parallel-group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

0 references

author name string

Charles M Fogarty

1

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Marcia Cyganowski

2

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

William A Palo

3

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Richard C Hom

4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

William A Craig

5

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

1854-1870

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. American Thoracic Society. Medical Section of the American Lung Association

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial treatment of community acquired pneumonia in adults: A conference report

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Community-acquired pneumonia guidelines--an international comparison: a view from Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of patients with community-acquired pneumonia in a primary care hospital: a critical evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of a new cephalosporin ME-1206 compared with other agents.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2980084-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(02)80084-4

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44261949&oldid=2108974616"